| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/20/2011 | CN102018216A Composition containing bifidobacteria for adjusting intestinal flora and enhancing immunity |
| 04/20/2011 | CN101708286B Chinese patent medicament for treating sjogren's syndrome and intractable oral ulcer, and preparation method thereof |
| 04/20/2011 | CN101503662B Microbial strain for antianaphylaxis symptom, composition thereof and method for producing interferon-gamma by using the microbial strain irritation cell |
| 04/20/2011 | CN101492430B Method for preparing high-purity cetirizine hydrochloride |
| 04/20/2011 | CN101401934B T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/20/2011 | CN101401898B Chinese medicinal composition for improving phylactic power |
| 04/20/2011 | CN101342218B Cactus powder processing method |
| 04/20/2011 | CN101302251B Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2450203C Capsular polysaccharide solubilisation and combination vaccines |
| 04/19/2011 | CA2422094C Vaccination method |
| 04/19/2011 | CA2400969C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine |
| 04/19/2011 | CA2319599C Delivery of immunogenic molecules via hbsag particles |
| 04/14/2011 | WO2011044375A2 Apogossypolone derivatives as anticancer agents |
| 04/14/2011 | WO2011044307A1 Phenyloxadiazole derivatives as pgds inhibitors |
| 04/14/2011 | WO2011043524A1 Anticancer composition containing human-derived adult stem cells |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043359A1 Pharmaceutical product containing aromatic heterocyclic compound |
| 04/14/2011 | WO2011043136A1 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042473A2 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042466A1 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| 04/14/2011 | WO2011041886A1 Vaccines comprising heat-sensitive transgenes |
| 04/14/2011 | WO2011041847A1 Chaperonin 10 variants |
| 04/14/2011 | WO2011021203A3 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 04/14/2011 | WO2010123243A3 Composition containing a testis extract for treating or preventing diseases |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110086926 Disabling thymus gland as a new method for treatment of multiple sclerosis |
| 04/14/2011 | US20110086906 Methods for treatment or prevention of diseases associated with functional disorder of regulatory t cells |
| 04/14/2011 | US20110086900 Compositions for prevention/prophylactic treatment of poison ivy dermatitis |
| 04/14/2011 | US20110086895 Thiazolidinedione energy restriction-mimetic agents |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086866 Inhibitors of bruton's tyrosine kinase |
| 04/14/2011 | US20110086859 Alkyl substituted indoloquinoxalines |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086842 Pyrimidines as PLK inhibitors |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086835 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086799 GnRH II Analogs and Uses Thereof in the Immune System |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086102 Delayed release compositions |
| 04/14/2011 | US20110086087 Process and Formulation for Immunizing Fish in Aquaculture Systems |
| 04/14/2011 | US20110086066 Methods to Increase Transgene Expression From Bacterial-Based Delivery Systems by Co-Expressing Suppressors of the Eukaryotic Type I Interferon Response |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086061 Cancer Detection Methods and Reagents |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086056 Methods for the early diagnosis of ovarian cancer |
| 04/14/2011 | US20110086055 Her2 peptides |
| 04/14/2011 | US20110086054 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
| 04/14/2011 | US20110086053 Glycolipids And Analogues Thereof As Antigens For NKT Cells |
| 04/14/2011 | US20110086052 Activation of innate and adaptive immune responses by a ginseng extract |
| 04/14/2011 | US20110086051 System and method for monitoring and optimizing immune status in transplant recipients |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086049 Receptor Modulators |
| 04/14/2011 | US20110086037 Method of treating inflammatory disorders |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086026 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 04/14/2011 | US20110086023 Combination antihistamine medication |
| 04/14/2011 | US20110086020 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/14/2011 | US20110086004 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/14/2011 | US20110086003 Stabilization of hydrophobic protein therapeutic agents |
| 04/14/2011 | US20110085981 Glycan-based drugs, therapies and biomarkers |
| 04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
| 04/14/2011 | CA2777007A1 An immunoactivation blood perfusion filter for the treatment of malignant tumors |
| 04/14/2011 | CA2776922A1 Vaccines comprising heat-sensitive transgenes |
| 04/14/2011 | CA2776874A1 Chaperonin 10 variants |
| 04/14/2011 | CA2776242A1 Phenyloxadiazole derivatives as pgds inhibitors |
| 04/14/2011 | CA2775902A1 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| 04/14/2011 | CA2773576A1 Apogossypolone derivatives as anticancer agents |
| 04/13/2011 | EP2308989A2 Pectin hydrolysis products |
| 04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308888A1 Anti-IL-6 antibodies, compositions, methods and uses |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308860A1 Immunosuppressor based on the interruption of tcr-nck interaction |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |